|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Eprosartan#Adult Indications and Dosage]] |
| {{Eprosartan}}
| |
| {{CMG}}; {{AE}} {{SS}}
| |
| | |
| ==Dosage and Administration==
| |
| | |
| The usual recommended starting dose of TEVETEN® is 600 mg once daily when used as monotherapy in patients who are not volume-depleted (see WARNINGS, Hypotension in Volume- and/or Salt-Depleted Patients). TEVETEN® can be administered once or twice daily with total daily doses ranging from 400 mg to 800 mg. There is limited experience with doses beyond 800 mg/day.
| |
| | |
| If the [[antihypertensive]]effect measured at trough using once-daily dosing is inadequate, a twice-a-day regimen at the same total daily dose or an increase in dose may give a more satisfactory response. Achievement of maximum blood pressure reduction in most patients may take 2 to 3 weeks.
| |
| | |
| TEVETEN® may be used in combination with other [[antihypertensive]]agents such as thiazide [[diuretics]] or [[calcium channel blockers]] if additional blood-pressure-lowering effect is required. Discontinuation of treatment with eprosartan does not lead to a rapid rebound increase in blood pressure.
| |
| | |
| Elderly, Hepatically Impaired or Renally Impaired Patients
| |
| | |
| No initial dosing adjustment is generally necessary for elderly or hepatically impaired patients or those with renal impairment. No initial dosing adjustment is generally necessary in patients with moderate and severe [[renal impairment]], with maximum dose not exceeding 600 mg daily.
| |
| | |
| TEVETEN® may be taken with or without food.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = TEVETEN (EPROSARTAN MESYLATE) TABLET [ABBOTT LABORATORIES] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7cde57a7-eded-4c22-b1c7-98afc5546997 | publisher = | date = | accessdate = 20 February 2014 }}</ref>
| |
| | |
| ==References==
| |
| {{Reflist}}
| |
| | |
| {{Angiotensin II receptor antagonists}}
| |
| | |
| [[Category:Angiotensin II receptor antagonists]]
| |
| [[Category:Imidazoles]]
| |
| [[Category:Thiophenes]]
| |
| [[Category:Benzoic acids]]
| |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |